For years, hospital admission often meant disconnecting patients from their personal diabetes devices. Continuous glucose monitors (CGMs) and insulin pumps were frequently removed, even when patients had used them successfully at home. However, the 2026 American Diabetes Association (ADA) Standards of Care introduce a significant shift in how hospitals approach …
Read More »Fasting or Random Glucose Testing? Navigating the New Rules for Cancer Therapy–Induced Hyperglycemia
As cancer treatment becomes increasingly sophisticated, clinicians are encountering a growing metabolic challenge. Cancer therapy–induced hyperglycemia has emerged as an important concern with the expanding use of immunotherapies and targeted therapies. In some patients, hyperglycemia develops gradually. In others, particularly those receiving immune checkpoint inhibitors, severe diabetes and diabetic ketoacidosis …
Read More »The Diabetes Conversation Patients Don’t Want to Start: Addressing Sexual Health in Clinical Practice
Sexual health remains one of the most overlooked aspects of diabetes management, despite its significant impact on quality of life. While clinicians routinely discuss glycemic control, cardiovascular risk, and medication adherence, conversations about sexual function are often avoided by both patients and healthcare providers. Yet sexual health concerns related to …
Read More »The Overnight Danger Many Clinicians Miss: Why Nighttime Hypoglycemia Still Matters
Many healthcare providers focus heavily on daytime glucose control, yet some of the most dangerous hypoglycemic episodes occur while patients are asleep. Despite major advances in insulin therapy and glucose monitoring, nocturnal hypoglycemia remains a significant clinical concern for people living with diabetes. Because symptoms often go unnoticed during sleep, …
Read More »Could Hearing Loss Be an Early Warning Sign of Future Diabetes Complications?
For many people living with diabetes, complications such as retinopathy, nephropathy, and neuropathy are well-recognized concerns. However, growing evidence suggests that hearing loss may deserve a place on that list as well. Researchers are increasingly examining whether hearing loss reflects the same vascular and neurologic damage that contributes to complications …
Read More »What Your Patient’s Skin May Be Telling You About Their Diabetes Risk
The skin is often described as a window into overall health, and in patients with diabetes or prediabetes, it may provide some of the earliest visible signs of underlying metabolic dysfunction. While laboratory testing remains the cornerstone of diabetes diagnosis, clinicians who recognize key skin manifestations of diabetes can identify …
Read More »When Depression Treatment Conflicts With Diabetes Management
Depression and diabetes management often overlap in ways that make treatment decisions more complicated. Patients with type 2 diabetes frequently experience depression, and depression can make daily self-care harder. However, some commonly prescribed antidepressants and psychotropic medications may contribute to weight gain, worsen insulin resistance, or complicate long-term metabolic control. …
Read More »The Corticosteroid Conundrum: Managing Steroid-Induced Hyperglycemia in Primary Care
Patients treated with corticosteroids for asthma, COPD exacerbations, rheumatologic disease, inflammatory bowel disease, or cancer-related complications often develop significant elevations in blood glucose. In many cases, these patients have no prior history of diabetes. Yet within days of therapy initiation, blood glucose levels can rise dramatically, creating a challenging clinical …
Read More »Diabulimia in Type 1 Diabetes: The Warning Signs Clinicians Often Miss
Patients with type 1 diabetes already face the daily burden of balancing insulin, food intake, exercise, and glucose monitoring. However, for some individuals, insulin becomes more than a treatment tool. It becomes a method for weight control. This dangerous behavior, commonly referred to as diabulimia, involves the intentional restriction or …
Read More »Misdiagnosed as Type 2? Why We Need to Screen More Adults for LADA
Up to 10% of adults diagnosed with type 2 diabetes may actually have Latent Autoimmune Diabetes in Adults (LADA), yet many cases remain undetected for years. Because symptoms often develop slowly, LADA is frequently mistaken for traditional type 2 diabetes. However, the wrong diagnosis can delay insulin therapy, worsen glucose …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.